Skip to content

Effects of neuromuscular stimulation on quadriceps in chronic obstructive pulmonary disease (COPD)

The effects of unilateral neuromuscular stimulation on quadriceps muscle morphology, architecture and function in chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN87439020
Enrollment
40
Registered
2011-05-03
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory disease (chronic obstructive pulmonary disease) Respiratory Respiratory disease

Interventions

1. Single leg resistance training (control): Three supervised quadriceps resistance training sessions per week for 6 weeks. 2. Single leg neuromuscular elctrical stimulation (experimental): Three sup

Sponsors

University Hospitals of Leicester NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of COPD 2. Forced expiratory volume in one second (FEV1) less than 50% predicted 3. FEV1/forced vital capacity (FVC) ratio less than 70% 4. Medical Research Council (MRC) dyspnoea score greater than 3 5. Clinically stable at time of recruitment (greater than 4 weeks exacerbation free) 6. Aged greater than 40 years, both sexes

Exclusion criteria

Exclusion criteria: 1. Uses long-term oral corticosteroids 2. Uses anticoagulation (e.g. warfarin) 3. Impaired clotting 4. Long-term oxygen therapy 5. Comorbid condition preventing exercise training, causing exercise limitation 6. Pulmonary rehabilitation in last 12 months 7. Condition causing intramuscular inflammation (e.g. type two diabetes [T2D], rheumatoid arthritis, inflammatory bowel disease)

Design outcomes

Primary

MeasureTime frame
Muscle Mass: quadriceps mass change at 6 weeks

Secondary

MeasureTime frame
1. Neural Adaptations to Training at 6 weeks 2. Muscle Architecture including pennation angle at 6 weeks 3. Muscle Morphology including fibre type at 6 weeks 4. Muscle hypertrophy including satellite cell activity and cross sectional area at 24 hours and 6 weeks 5. Acute local inflammation response at 24 hours and 6 weeks 6. Functional change in quadriceps strength at 6 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026